FRIDAY, Sept. 19 HealthDay News — Resveratrol, the compound in red wine that previous research has linked to longevity, has shown promise in an animal model of multiple sclerosis.

Mice with the MS-like condition called Wallerian degeneration slow WldS showed an initial weight gain when given resveratrol, researchers at the University of Utah reported Thursday at the World Congress on Treatment and Research in Multiple Sclerosis, in Montreal.

The weight gain occurred in the first two weeks of treatment. A microscopic study of nerve cell tissue at five weeks did not show any positive effect.

“They didn’t look at the tissue under the microscope in the first two weeks,” said Dr. John Richert, executive vice president for the research and clinical program of the Multiple Sclerosis Society. “Obviously, lots of things can make animals gain weight.”

But weight gain of any kind is an encouraging sign in MS treatment, Richert said. “In inflammatory animal models of MS, one of the tell-tale clinical signs of the disease is weight loss. Weight loss often goes hand in hand with loss of neurological function.”

The study “poses some questions,” Richert said. “Obviously, a lot more needs to be done to see if the weight gain shows a beneficial effect on the disease process. This is evidence that it should be studied further.”

read the rest: Red Wine Molecule Might Battle MS

Comments

One Response to “Red Wine Molecule Might Battle MS”

  1. resveratrol wine on October 17th, 2008 2:19 pm

    Let’s all hope that God has all along provided us with the weapon to fight our diseases, it seems hard to believe at first but red wine is lately in the news for having an inconceivably enormous array of health benefits why not MS then?

Leave a Reply




  •  

     

     

     

  •  

     

     

  • Important Notice

    This site posts excerpts and summaries of articles of interest to people with multiple sclerosis and their families, along with links to the full articles in the journals in which they were published.

    I have multiple sclerosis (primary progressive), but I am neither a doctor nor a research scientist. I have no connection to the people mentioned in these articles, and have no more information about the subject of any given article than is contained in the article itself. Please do not ask me for medical advice or how to contact people mentioned in these articles. If contact information is not contained in the article itself, your best bet is to Google the name of the person, company or clinic you are seeking.